Filter
389
Text search:
guidelines
for
pharmacovigilance
Featured
Recommendations
49
New Publications
115
Language
Document type
No document type
196
Guidelines
72
Studies & Reports
46
Strategic & Response Plan
32
Manuals
24
Training Material
7
Fact sheets
6
Situation Updates
3
Resource Platforms
1
Infographics
1
Online Courses
1
Countries / Regions
Kenya
23
Ghana
15
Uganda
15
India
14
Global
14
Western and Central Europe
13
Nigeria
12
Namibia
12
South Africa
11
Ethiopia
10
Eastern Europe
10
Nepal
9
Zambia
8
Rwanda
8
Sierra Leone
7
Tanzania
7
Malawi
7
Cambodia
5
South–East Asia Region
5
Latin America and the Carribbean
5
Liberia
4
Senegal
4
Bangladesh
4
Zimbabwe
3
Botswana
3
Lesotho
3
West and Central Africa
3
Russia
3
Congo, Democratic Republic of
2
Haiti
2
Philippines
2
Indonesia
2
Mozambique
2
Sudan
2
Eswatini/ Swaziland
2
Brazil
2
Myanmar / Burma
2
East and Southern Africa
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Asia
2
Africa
2
Guinea
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Cameroon
1
Togo
1
Pakistan
1
Jordan
1
Afghanistan
1
Lebanon
1
Syria
1
Thailand
1
Gambia
1
Benin
1
Argentina
1
Burundi
1
Ukraine
1
Libya
1
Sri Lanka
1
Yemen
1
Western Pacific Region
1
Paraguay
1
Bhutan
1
Southern Africa
1
Laos
1
Georgia
1
Vietnam
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
197
Clinical Guidelines
49
Public Health
9
Pharmacy & Technologies
8
Capacity Building
6
Women & Child Health
6
Key Resources
6
Toolboxes
TB
47
Pharmacy
44
AMR
32
Malaria
31
HIV
22
COVID-19
21
NTDs
17
NCDs
5
Rapid Response
3
Refugee
2
Caregiver
2
Planetary Health
2
Ebola & Marburg
1
Cholera
1
Polio
1
Specific Hazards
1
2.0 Rapid Response
1
The WHO guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-friendly and easy-to-nav
...
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicin
...
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO,
...
The PHC STGs and EML should be used by healthcare workers providing care at clinics, community health centres, and gateway clinics at hospitals.
Pharmaceutical and Therapeutics Committees (PTCs) are responsible for ensuring the availability of medi
...
The manual is written for clinicians working at the district hospital (first-level referral care) who diagnose and manage sick adolescents and adults in resource constrained settings. It aims to support clinical reasoning, and to provide an effectiv
...
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibiotics. The severity of the consequences is clear to
...
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in
...
The "Primary Healthcare Standard Treatment Guidelines and Essential Medicines List" by the South African National Department of Health provides evidence-based guidelines
...
This document was prepared in response to a need to review and potentially update the current recommendations for the antibiotic treatment of both inpatient and outpatient management of severe acute malnutrition (SAM). The current recommendations (T
...
Rwanda Guidelines for variation to registered pharmaceutical products.
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities
...
